Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-120-4 | CAS number: 12070-08-5
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
The results from a bioelution assay demonstrated very low titanium release from titanium carbide in simulated gastric fluid. Therefore, very low bioavailability can be expected via the oral route.
In a read-across study, titanium dioxide did not show adverse effects after chronic oral repeated dose exposure in reproductive organs mice and rats.
In addition, the results from the bioelution tests with TiC together with the insolubility of the test material in a transformation/dissolution test lead to the conclusion that no to very low bioavailability can be expected via the inhalation and dermal route.
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Reproductive effects observed:
- not specified
Reference
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No substance-specific data on toxicity to reproduction is available for titanium carbide.
Bioelution results of titanium carbide in four artificial body fluids which served as a surrogate for bioavailability in different tissues, demonstrated very low release of titanium ions in general (Cappellini D., 2012, see IUCLID section 7.1.1).
The amount of soluble titanium was below detection limit in artificial perspiration fluid and simulated interstitial fluid, representing dermal/sweat and interstitial milieus in the deep lung, respectively.
Very limited amounts of soluble titanium could be detected in artificial lysosomal fluid (0.08% titanium release after 24 hours) and simulated gastric fluid (0.56% titanium release after 24 hours). Based on these results, very limited absorption and systemic distribution can be expected and an exposure of the reproductive organs in male and female rats to titanium carbide is rather unlikely. Thus, any specific effects on reproduction are not to be expected.
This assumption is supported by investigations during a chronic repeated dose toxicity read-across study via the oral route in mice and rats with titanium dioxide.
No adverse effects and no effects on reproductive organs including uterus, testes, ovaries and mammary gland were observed after a treatment period of 103 weeks at dietary levels up to 50,000 ppm (equivalent to 6,500 mg/kg bw/day in mice and 2,500 mg/kg bw/day in rats). These concentrations largely exceed the maximum recommended concentration in thereproductive and developmental toxicity screening study (1,000 mg/kg bw/day).
For the reasons presented above, conducting a reproduction and developmental toxicity screening study will therefore not provide any further insights in the toxicity of titanium carbide. Therefore, and especially in light of animal welfare, it is scientifically not justified to conduct a further reproductive and developmental toxicity screening study in rats (in accordance with Annex X, section 8.7, column 2 of Regulation (EC) 1907/2006).
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No substance-specific data on toxicity to reproduction is available for titanium carbide.
Bioelution results of titanium carbide in four artificial body fluids which served as a surrogate for bioavailability in different tissues, demonstrated very low release of titanium ions in general.
The amount of soluble titanium was below detection limit in artificial perspiration fluid and simulated interstitial fluid, representing dermal/sweat and interstitial milieus in the deep lung, respectively.
Very limited amounts of soluble titanium could be detected in artificial lysosomal fluid (0.08% titanium release after 24 hours) and simulated gastric fluid (0.56% titanium release after 24 hours). Based on these results, very limited absorption and systemic distribution can be expected and an exposure of the reproductive organs in male and female rats to titanium carbide is rather unlikely. Thus, any specific effects on reproduction are not to be expected.
This assumption is supported by investigations during a chronic repeated dose toxicity read-across study via the oral route in mice and rats with titanium dioxide.
No adverse effects and no effects on reproductive organs including uterus, testes, ovaries and mammary gland were observed after a treatment period of 103 weeks at dietary levels up to 50,000 ppm (equivalent to 6,500 mg/kg bw/day in mice and 2,500 mg/kg bw/day in rats). These concentrations largely exceed the maximum recommended concentration in the reproductive and developmental toxicity screening study (1,000 mg/kg bw/day).
For the reasons presented above, conducting a reproduction and developmental toxicity screening study will therefore not provide any further insights in the toxicity of titanium carbide. Therefore, and especially in light of animal welfare, it is scientifically not justified to conduct a further reproductive and developmental toxicity screening study in rats (in accordance with Annex X, section 8.7, column 2 of Regulation (EC) 1907/2006).
Justification for classification or non-classification
Based on the results of a bioelution assay in different simulated body fluids and solubility data for the test item titanium carbide, no to very low systemic bioavailability can be expected.
Therefore, exposure of the reproductive organs in male and female rats to titanium carbide is rather unlikely. Thus, any specific effects on reproduction are not to be expected and classification for Reproductive toxicity according to Regulation (EC) 1272/2008 is not warranted.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
